Tianpei Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tianpei Ma has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Jiaqiang Liao
Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China
4 shared publications Jiayuan Li
Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University , Chengdu
4 shared publicationsKe Jiang
Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University , Chengdu
4 shared publicationsXia Jiang
Department of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University , Chengdu
4 shared publicationsXin Chen
Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University , Chengdu
4 shared publicationsXinyang Dui
Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University , Chengdu
4 shared publications
Latest Publications
- 28 August 2026
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (10)
Metabolomic profiling of telomere length: associations with aging-related phenotypes and modifiable lifestyle factors in Chinese older adults
Background: Telomere length (TL) is a well-established biomarker of cellular senescence, yet the metabolic profile of TL and its associations with aging-related phenotypes and responses to modifiable lifestyle factors remain unclear. Methods: TL was measured using quantitative real-time polymerase chain reaction (qPCR) in 282 participants from the West China Health and Aging Cohort (WCHAC). Plasma metabolites were analyzed using liquid chromatography-tandem mass spectrometry. TL-associated metabolic signatures (Met-TL) were identified through elastic net regression models. Associations between Met-TL and aging-related phenotypes and modifiable lifestyle factors were evaluated using linear and logistic regression models in a larger, non-overlapping sample of 5957 WCHAC participants. Furthermore, we employed mediation analysis to explore the mediating effects of Met-TL between lifestyle factors and aging-related diseases. Results: We identified a plasma metabolite signature comprising 26 metabolites explaining 17.5% of TL variance. Met-TL significantly associated with aging-related phenotypes (44 Bonferroni-corrected associations) and modifiable lifestyle factors (4 associations). Notably, Met-TL showed robust associations with steatohepatitis and hepatic biomarkers. Mediation analysis revealed that Met-TL partially explained the protective association between healthy lifestyle and steatohepatitis, with a mediation proportion of 8.2%. Conclusion: These findings provide novel insights into the metabolic profile of TL in older adults. The Met-TL may serve as a promising biomarker of cellular aging, particularly in identifying liver dysfunction, facilitating the development of personalized aging monitoring and anti-aging intervention strategies.
- 28 August 2026
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (10)
Metabolomic profiling of telomere length: associations with aging-related phenotypes and modifiable lifestyle factors in Chinese older adults
Background: Telomere length (TL) is a well-established biomarker of cellular senescence, yet the metabolic profile of TL and its associations with aging-related phenotypes and responses to modifiable lifestyle factors remain unclear. Methods: TL was measured using quantitative real-time polymerase chain reaction (qPCR) in 282 participants from the West China Health and Aging Cohort (WCHAC). Plasma metabolites were analyzed using liquid chromatography-tandem mass spectrometry. TL-associated metabolic signatures (Met-TL) were identified through elastic net regression models. Associations between Met-TL and aging-related phenotypes and modifiable lifestyle factors were evaluated using linear and logistic regression models in a larger, non-overlapping sample of 5957 WCHAC participants. Furthermore, we employed mediation analysis to explore the mediating effects of Met-TL between lifestyle factors and aging-related diseases. Results: We identified a plasma metabolite signature comprising 26 metabolites explaining 17.5% of TL variance. Met-TL significantly associated with aging-related phenotypes (44 Bonferroni-corrected associations) and modifiable lifestyle factors (4 associations). Notably, Met-TL showed robust associations with steatohepatitis and hepatic biomarkers. Mediation analysis revealed that Met-TL partially explained the protective association between healthy lifestyle and steatohepatitis, with a mediation proportion of 8.2%. Conclusion: These findings provide novel insights into the metabolic profile of TL in older adults. The Met-TL may serve as a promising biomarker of cellular aging, particularly in identifying liver dysfunction, facilitating the development of personalized aging monitoring and anti-aging intervention strategies.
- Open Access
- 23 August 2026
- Published by Wiley in Aging Cell
- Vol. 25 (9) , e70657
Metabolic Profiling of Epigenetic Aging and Its Associations With Aging‐Related Phenotypes and Modifiable Lifestyle Factors
Epigenetic aging biomarkers are well‐established hallmarks of biological aging, yet their metabolic underpinnings remain largely unexplored. Here, we characterized metabolic signatures associated with five epigenetic aging biomarkers (HorvathAge, HannumAge, DNAmPhenoAge, DunedinPACE, and DNAmTL) and examined their clinical relevance and potential determinants in 7162 Chinese older adults from two cohorts (primary and validation). We observed both shared and distinct metabolic associations across epigenetic aging biomarkers. Metabolic signatures of epigenetic aging biomarkers were derived using elastic net regression, showing moderate correlations with the corresponding epigenetic aging biomarkers ( r = 0.21–0.36 in internal testing set, p < 0.05), with external replication further validating metabolic signatures of DNAmPhenoAge, DunedinPACE, and DNAmTL ( r = 0.18–0.29, p < 0.05). These five metabolic signatures of epigenetic age acceleration (EAA) exhibited 279 significant associations with aging‐related phenotypes including higher disease risk, poorer health status, and adverse clinical indicators. Gallstones, chronic kidney disease, and hepatitis, along with renal‐, hepatic‐ and metabolic‐related clinical indicators, were consistently associated with multiple metabolic signatures of EAA. Smoking status, alcohol consumption, body mass index (BMI), and physical activity were identified as modifiable lifestyle factors associated with metabolic signatures of EAA, with BMI showing the most consistent associations. Metabolic signatures of DunedinPACE and DNAmPhenoAA exhibited the most extensive associations with aging‐related phenotypes and modifiable lifestyle factors in both primary and validation cohorts. These findings provide novel insights into the metabolic correlates of epigenetic aging biomarkers and underscore the potential of metabolomics‐informed metrics of epigenetic aging as informative indicators of physiological decline and lifestyle effects.
- 23 August 2026
- Published by Wiley in Aging Cell
- Vol. 25 (9) , e70657
Open AccessMetabolic Profiling of Epigenetic Aging and Its Associations With Aging‐Related Phenotypes and Modifiable Lifestyle Factors
Epigenetic aging biomarkers are well‐established hallmarks of biological aging, yet their metabolic underpinnings remain largely unexplored. Here, we characterized metabolic signatures associated with five epigenetic aging biomarkers (HorvathAge, HannumAge, DNAmPhenoAge, DunedinPACE, and DNAmTL) and examined their clinical relevance and potential determinants in 7162 Chinese older adults from two cohorts (primary and validation). We observed both shared and distinct metabolic associations across epigenetic aging biomarkers. Metabolic signatures of epigenetic aging biomarkers were derived using elastic net regression, showing moderate correlations with the corresponding epigenetic aging biomarkers ( r = 0.21–0.36 in internal testing set, p < 0.05), with external replication further validating metabolic signatures of DNAmPhenoAge, DunedinPACE, and DNAmTL ( r = 0.18–0.29, p < 0.05). These five metabolic signatures of epigenetic age acceleration (EAA) exhibited 279 significant associations with aging‐related phenotypes including higher disease risk, poorer health status, and adverse clinical indicators. Gallstones, chronic kidney disease, and hepatitis, along with renal‐, hepatic‐ and metabolic‐related clinical indicators, were consistently associated with multiple metabolic signatures of EAA. Smoking status, alcohol consumption, body mass index (BMI), and physical activity were identified as modifiable lifestyle factors associated with metabolic signatures of EAA, with BMI showing the most consistent associations. Metabolic signatures of DunedinPACE and DNAmPhenoAA exhibited the most extensive associations with aging‐related phenotypes and modifiable lifestyle factors in both primary and validation cohorts. These findings provide novel insights into the metabolic correlates of epigenetic aging biomarkers and underscore the potential of metabolomics‐informed metrics of epigenetic aging as informative indicators of physiological decline and lifestyle effects.
- 24 January 2026
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (4)
Sleep, metabolites, and global cognition: a mediation analysis of plasma metabolic profiles in the West China Health and Aging Cohort
Background: Growing evidence connects sleep disorders with cognitive impairment in older adults, though underlying biological mechanisms remain unclear. We investigated how plasma metabolic profiles mediate the relationship between sleep patterns and global cognitive function. Methods: In a cross-sectional analysis of 3888 participants aged ≥60 years from the West China Health and Aging Cohort, we analyzed associations between 221 metabolites with both sleep characteristics and cognitive outcomes (assessed via Mini-Mental State Examination), evaluated mediating roles of individual metabolites and composite metabolite scores, and assessed joint associations of genetic susceptibility, sleep patterns, and metabolic profiles with cognitive function. Analyses were adjusted for demographic, lifestyle, comorbidity, and medication factors. Results: We identified 93 metabolites associated with sleep characteristics and 26 linked to cognitive outcomes. Four individual metabolites, including ketoleucine, dodecanoic acid, ribonic acid, and ortho-hydroxyphenylacetic acid, mediated 1.67%-3.25% of the sleep-cognition associations. Composite metabolite scores, both unrestricted and those restricted to branched-chain amino acid (BCAA) pathways, demonstrated stronger mediation effects, with proportions reaching up to 13.6%. Participants with concurrent exposure to poor sleep, high genetic risk, and adverse metabolic profiles showed significantly worse cognitive outcomes compared to those without these risk factors, with effect sizes exceeding those in single or dual exposure groups. Conclusions: Plasma metabolic signatures, particularly those involving BCAA metabolism, may serve as biological intermediaries linking poor sleep to worse cognitive function in older adults and could help identify populations at an elevated risk of cognitive impairment. Longitudinal and experimental studies are required to validate these associations and develop metabolic-based strategies for cognitive preservation.
- 24 January 2026
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (4)
Sleep, metabolites, and global cognition: a mediation analysis of plasma metabolic profiles in the West China Health and Aging Cohort
Background: Growing evidence connects sleep disorders with cognitive impairment in older adults, though underlying biological mechanisms remain unclear. We investigated how plasma metabolic profiles mediate the relationship between sleep patterns and global cognitive function. Methods: In a cross-sectional analysis of 3888 participants aged ≥60 years from the West China Health and Aging Cohort, we analyzed associations between 221 metabolites with both sleep characteristics and cognitive outcomes (assessed via Mini-Mental State Examination), evaluated mediating roles of individual metabolites and composite metabolite scores, and assessed joint associations of genetic susceptibility, sleep patterns, and metabolic profiles with cognitive function. Analyses were adjusted for demographic, lifestyle, comorbidity, and medication factors. Results: We identified 93 metabolites associated with sleep characteristics and 26 linked to cognitive outcomes. Four individual metabolites, including ketoleucine, dodecanoic acid, ribonic acid, and ortho-hydroxyphenylacetic acid, mediated 1.67%-3.25% of the sleep-cognition associations. Composite metabolite scores, both unrestricted and those restricted to branched-chain amino acid (BCAA) pathways, demonstrated stronger mediation effects, with proportions reaching up to 13.6%. Participants with concurrent exposure to poor sleep, high genetic risk, and adverse metabolic profiles showed significantly worse cognitive outcomes compared to those without these risk factors, with effect sizes exceeding those in single or dual exposure groups. Conclusions: Plasma metabolic signatures, particularly those involving BCAA metabolism, may serve as biological intermediaries linking poor sleep to worse cognitive function in older adults and could help identify populations at an elevated risk of cognitive impairment. Longitudinal and experimental studies are required to validate these associations and develop metabolic-based strategies for cognitive preservation.
- 13 December 2025
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (3)
Interplay of accelerated biological aging, lifestyle factors, and genetic susceptibility in cognitive function: a community study
Cognitive impairment is a significant health concern in aging populations, but the interplay between biological aging, lifestyle factors, and genetic susceptibility remains unclear. This study examined whether accelerated biological aging is associated with cognitive impairment, whether lifestyle modifies this association, and how genetic background influences these relationships in Chinese older adults. In this cross-sectional study (2022-2023), 7033 participants from southwestern China were included. Accelerated biological aging was calculated as the residual difference between biological age (based on 10 biomarkers) and chronological age. Lifestyle was assessed via a composite index (smoking, alcohol, physical activity, diet, sleep). Cognitive function was measured using the Chinese Mini-Mental State Examination (C-MMSE), and genetic risk was evaluated through polygenic scores and APOE ε4 status. Linear and logistic regression models assessed associations between accelerated aging and cognition. Accelerated biological aging was associated with lower MMSE scores ( β = −0.243, 95% CI: −0.354, −0.133) and higher cognitive impairment prevalence (OR = 1.098, 95% CI: 1.040, 1.158). An unhealthy lifestyle exacerbated cognitive impairment in biologically older individuals (RERI = 0.25). Those with both accelerated aging and unhealthy lifestyle had the lowest MMSE scores ( β = −1.424, 95% CI: −1.846, −1.003) and highest odds of cognitive impairment (OR = 1.467, 95% CI: 1.194, 1.803). These effects were consistent across all genetic background subgroups. Accelerated aging was associated with lower cognitive function, especially in individuals with unhealthy lifestyles, regardless of genetic susceptibility. This highlights lifestyle modification as a potential intervention target for aging-related cognitive impairment.
- 13 December 2025
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (3)
Interplay of accelerated biological aging, lifestyle factors, and genetic susceptibility in cognitive function: a community study
Cognitive impairment is a significant health concern in aging populations, but the interplay between biological aging, lifestyle factors, and genetic susceptibility remains unclear. This study examined whether accelerated biological aging is associated with cognitive impairment, whether lifestyle modifies this association, and how genetic background influences these relationships in Chinese older adults. In this cross-sectional study (2022-2023), 7033 participants from southwestern China were included. Accelerated biological aging was calculated as the residual difference between biological age (based on 10 biomarkers) and chronological age. Lifestyle was assessed via a composite index (smoking, alcohol, physical activity, diet, sleep). Cognitive function was measured using the Chinese Mini-Mental State Examination (C-MMSE), and genetic risk was evaluated through polygenic scores and APOE ε4 status. Linear and logistic regression models assessed associations between accelerated aging and cognition. Accelerated biological aging was associated with lower MMSE scores ( β = −0.243, 95% CI: −0.354, −0.133) and higher cognitive impairment prevalence (OR = 1.098, 95% CI: 1.040, 1.158). An unhealthy lifestyle exacerbated cognitive impairment in biologically older individuals (RERI = 0.25). Those with both accelerated aging and unhealthy lifestyle had the lowest MMSE scores ( β = −1.424, 95% CI: −1.846, −1.003) and highest odds of cognitive impairment (OR = 1.467, 95% CI: 1.194, 1.803). These effects were consistent across all genetic background subgroups. Accelerated aging was associated with lower cognitive function, especially in individuals with unhealthy lifestyles, regardless of genetic susceptibility. This highlights lifestyle modification as a potential intervention target for aging-related cognitive impairment.
- Open Access
- 31 October 2025
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 54
The Application and Comparison of the Pediatric Voice Handicap Index and Acoustic Analysis in Pediatric Benign Voice Disorders
Importance: There are many methods for pediatric voice assessment, but each has its own limitations. Currently, there are few studies that have compared the outcomes of subjective and objective evaluation methods in children with voice disorders. Objective: To apply and compare the pediatric Voice Handicap Index (pVHI) with acoustic analysis in pediatric benign voice disorders. Design: Case-control study. Setting: This study was conducted at a single institution. Participants: Pediatric participants with and without benign voice disorders were included from August 2021 to April 2023. Intervention or Exposures: The questionnaire results for the pVHI were obtained, and acoustic analysis was conducted. Main Outcome Measures: The main outcomes included the pVHI scores, acoustic parameters, and the Pearson Correlation Coefficient. Results: Out of the 338 participants, 160 children were diagnosed with voice disorders, whereas 178 did not exhibit such conditions. The total scores and those of each subscale were significantly higher in the patient group than in the control group ( P < .05). Significant differences were also observed in the fundamental frequency (228.13 ± 66.78 vs 253.65 ± 47.21), jitter (2.08 ± 2.59 vs 2.42 ± 1.75), shimmer (8.52 ± 5.78 vs 9.44 ± 3.69), harmonic to noise ratio (HNR) (0.50 ± 0.68 vs 0.65 ± 0.19), s/z ratio (1.46 ± 1.89 vs 0.99 ± 0.44), and maximum phonation time (6.08 ± 3.38 vs 7.82 ± 2.50) ( P < .05). When comparing the types of diseases, the physical dimension of the pVHI (17.43 ± 7.02 vs 15.29 ± 6.92 vs 13.32±7.71) and the HNR (0.39 ± 0.16 vs 0.41 ± 0.21 vs 0.75 ± 1.24) were most negatively affected in the vocal fold polyps group. Moderate to strong correlations were shown among the pVHI total and each subscale scores ( P < .05), while the highest r score was shown between the physical and the total scores of the pVHI (r = 0.882). Conclusions and Relevance: Pediatric patients with voice disorders exhibit more severe voice handicaps in both pVHI scores and acoustic parameters. The total score of the pVHI is moderately to strongly correlated with each subscale, whereas no strong correlation was presented between different acoustic parameters or between acoustic parameters and pVHI scores. This indicates that the two evaluation methods are not interchangeable; thus, a comprehensive evaluation is essential in clinical practice to prevent bias.
- 31 October 2025
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 54
Open AccessThe Application and Comparison of the Pediatric Voice Handicap Index and Acoustic Analysis in Pediatric Benign Voice Disorders
Importance: There are many methods for pediatric voice assessment, but each has its own limitations. Currently, there are few studies that have compared the outcomes of subjective and objective evaluation methods in children with voice disorders. Objective: To apply and compare the pediatric Voice Handicap Index (pVHI) with acoustic analysis in pediatric benign voice disorders. Design: Case-control study. Setting: This study was conducted at a single institution. Participants: Pediatric participants with and without benign voice disorders were included from August 2021 to April 2023. Intervention or Exposures: The questionnaire results for the pVHI were obtained, and acoustic analysis was conducted. Main Outcome Measures: The main outcomes included the pVHI scores, acoustic parameters, and the Pearson Correlation Coefficient. Results: Out of the 338 participants, 160 children were diagnosed with voice disorders, whereas 178 did not exhibit such conditions. The total scores and those of each subscale were significantly higher in the patient group than in the control group ( P < .05). Significant differences were also observed in the fundamental frequency (228.13 ± 66.78 vs 253.65 ± 47.21), jitter (2.08 ± 2.59 vs 2.42 ± 1.75), shimmer (8.52 ± 5.78 vs 9.44 ± 3.69), harmonic to noise ratio (HNR) (0.50 ± 0.68 vs 0.65 ± 0.19), s/z ratio (1.46 ± 1.89 vs 0.99 ± 0.44), and maximum phonation time (6.08 ± 3.38 vs 7.82 ± 2.50) ( P < .05). When comparing the types of diseases, the physical dimension of the pVHI (17.43 ± 7.02 vs 15.29 ± 6.92 vs 13.32±7.71) and the HNR (0.39 ± 0.16 vs 0.41 ± 0.21 vs 0.75 ± 1.24) were most negatively affected in the vocal fold polyps group. Moderate to strong correlations were shown among the pVHI total and each subscale scores ( P < .05), while the highest r score was shown between the physical and the total scores of the pVHI (r = 0.882). Conclusions and Relevance: Pediatric patients with voice disorders exhibit more severe voice handicaps in both pVHI scores and acoustic parameters. The total score of the pVHI is moderately to strongly correlated with each subscale, whereas no strong correlation was presented between different acoustic parameters or between acoustic parameters and pVHI scores. This indicates that the two evaluation methods are not interchangeable; thus, a comprehensive evaluation is essential in clinical practice to prevent bias.